The United States and Malawi have signed a five-year, US$936 million bilateral health cooperation Memorandum of Understanding (MOU) aimed at strengthening Malawi’s national healthcare system while protecting Americans from global infectious disease threats.
Announced on Monday, the agreement falls under the America First Global Health Strategy, a US policy framework that prioritizes safeguarding American citizens from infectious diseases while promoting self-reliance and accountability in partner countries’ health systems.
Under the MOU, the United States plans to provide up to US$792 million over five years, contingent on Congressional approval, to support Malawi’s efforts to combat HIV/AIDS, malaria, and other infectious diseases, as well as to bolster disease surveillance and outbreak response. Malawi, for its part, will increase its annual health spending by US$143.8 million during the life of the agreement, demonstrating a shared commitment to co-investment and national ownership.
The partnership is designed to leverage Malawi’s progress in managing the HIV/AIDS epidemic, particularly its ongoing efforts to meet the 95-95-95 goals—ensuring that 95% of people living with HIV know their status, 95% of those diagnosed receive treatment, and 95% of those on treatment achieve viral suppression. The MOU emphasizes sustainable, integrated service delivery models that Malawi’s government will maintain independently once the agreement concludes.
The new approach represents a shift away from parallel delivery systems managed by international NGOs, which have historically created separate healthcare workforce structures. By restoring responsibility to Malawi’s government, the MOU seeks to strengthen national leadership, accountability, and long-term sustainability in the health sector.
More Read
Under the agreement, Malawi will co-invest in a wide range of health priorities, including HIV/AIDS, tuberculosis, malaria, maternal and child health, polio, and global health security. The program also encourages the adoption of digital health solutions, extending services to rural populations and enhancing monitoring, reporting, and disease outbreak response capabilities.
Officials from both countries emphasized that the partnership balances support for Malawi’s healthcare system with protections for the American population. By fostering stronger disease surveillance and rapid outbreak response capabilities abroad, the initiative aims to reduce the risk of infectious diseases spreading across borders.
“This MOU is a critical step toward a durable, responsive, and sustainable Malawian health system,” a US State Department official said. “It ensures that Malawi maintains ownership and accountability for its health programs, while also safeguarding Americans from global health threats.”
Malawi’s Ministry of Health described the agreement as a transformational investment in the country’s healthcare infrastructure. Government officials noted that the combined financial support from the US and Malawi will improve access to life-saving treatments, strengthen human resources for health, and reinforce the country’s disease surveillance systems.
The MOU also underlines the United States’ commitment to co-investment and measurable results, with both countries agreeing to track outcomes in critical health areas. This model is intended to demonstrate the effectiveness of nationally led health interventions while ensuring transparency and accountability in the use of resources.
Experts said the agreement reflects a broader trend in global health assistance toward country-led, integrated approaches rather than reliance on external NGOs. By aligning funding and programmatic support with Malawi’s national health priorities, the partnership aims to create a long-lasting impact, enabling the country to sustain progress in infectious disease control even after the US-funded program ends.
For Malawi, the $936 million MOU offers a path to strengthened healthcare systems, better disease control, and expanded access to essential services, while reinforcing its role as a responsible partner in global health security. For the United States, it represents a strategic investment in preventing the spread of infectious diseases and protecting its citizens from global health threats.
